Pictured: CancerSmart Lecture
Video
By Jim Stallard, MA, Writer/Editor  |  Tuesday, February 5, 2013

In a recent discussion as part of Memorial Sloan Kettering’s CancerSmart lecture series, bladder cancer experts spoke about symptoms, risk factors, and the latest treatment options available.

Pictured: BCG
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, February 1, 2013

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Pictured: Kenneth Yu
In the Clinic
By Media Staff  |  Tuesday, January 29, 2013

New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.

Pictured: Mark Bilsky
In the O.R.
By Jim Stallard, MA, Writer/Editor  |  Friday, January 25, 2013

Our doctors have shown that tumors compressing the spinal cord can be controlled using less-invasive surgery combined with a precise, intense form of radiation therapy.

Pictured: Snehal Patel
Video
By Memorial Sloan Kettering  |  Wednesday, January 23, 2013

When Dr. Patel meets with patients and their families, he walks them step-by-step through the treatment plan and ensures that they receive the most-effective surgery, when that is the best approach for the patient.

Pictured: Lisa Sclafani
Video
By Memorial Sloan Kettering  |  Wednesday, January 16, 2013

Dr. Sclafani, who practices at Memorial Sloan Kettering Commack, wants newly diagnosed patients to leave her office with hope and with a plan of action for treating the cancer.

Pictured: Bernard Bochner
Video
By Memorial Sloan Kettering  |  Friday, January 11, 2013

Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.

Pictured: Charles Sawyers' Laboratory
In the Clinic
By Media Staff  |  Monday, January 7, 2013

The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan Kettering researchers.

Pictured: Prasad Adusumilli
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, January 3, 2013

A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Pictured: Richard Barakat
Video
By Memorial Sloan Kettering  |  Friday, December 28, 2012

Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.

Pictured: Tim Ahles
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 27, 2012

Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.

Pictured: Marcel R. M. van den Brink
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, December 21, 2012

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Center News

Stay Informed

Get the latest information about cancer care and research every month.